Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 With Neulasta
Clinical trial NCT02650973 · COMPLETED
Trial details
- NCT number
- NCT02650973
- Sponsor
- Coherus Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-06-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.